Suchergebnisse - "Laharie, David"

PubPharm (130)

1

Sexual health and fertility for individuals with inflammatory bowel disease

enthalten in: World journal of gastroenterology | 2019

von Leenhardt, R. | Rivière, P. | Papazian, P. | +4

2

Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease : A GETAID Multicentre Cohort Study

enthalten in: Journal of Crohn's & colitis | 2019

von Caron, B. | Peyrin-Biroulet, L. | Pariente, B. | +21

CommentIn: J Crohns Colitis. 2019 Sep 27;13(10):1237-1238. - PMID 31560065

3

Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

enthalten in: The New England journal of medicine | 2019

von Sands, B. | Peyrin-Biroulet, L. | Loftus, E. | +111

CommentIn: N Engl J Med. 2019 Sep 26;381(13):1279-1281. - PMID 31553842

4

Altered sleep quality is associated with Crohn’s disease activity: an actimetry study

enthalten in: Sleep and breathing | 2019

von Bazin, T. | Micoulaud Franchi, J. | Terras, N. | +4

5

Altered sleep quality is associated with Crohn’s disease activity: an actimetry study

enthalten in: Sleep and breathing | 2019

von Bazin, T. | Micoulaud Franchi, J. | Terras, N. | +4

6

Altered sleep quality is associated with Crohn’s disease activity: an actimetry study

enthalten in: Sleep and breathing | 2019

von Bazin, T. | Micoulaud Franchi, J. | Terras, N. | +4

7

Concise Commentary: Second Line Is Not Second Best—Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2019

von Rivière, P. | Laharie, D. | Marteau, P.

8

Concise Commentary: Second Line Is Not Second Best—Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2019

von Rivière, P. | Laharie, D. | Marteau, P.

9

Concise Commentary: Second Line Is Not Second Best—Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2019

von Rivière, P. | Laharie, D. | Marteau, P.

10

Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease : a prospective multi-centre cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2019

von Amiot, A. | Serrero, M. | Peyrin-Biroulet, L. | +97

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]